Company Profile

Vyluma is a private biopharmaceutical company focused on developing novel topical treatments (eye drops) to address significant unmet needs for ophthalmic diseases that are prevalent worldwide. The Vyluma team is committed to developing and commercializing transformative therapeutics to preserve patients’ vision and improve their quality of life. In partnership with eye care clinicians, we are driven to transform the current standard of care with a promising pipeline of novel candidates.